Gardner Lewis Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-528,711
Closed -$52.5M 109
2019
Q3
$52.5M Buy
528,711
+115,543
+28% +$11M 7.86% 1
2019
Q2
$38.2M Buy
413,168
+157,873
+62% +$15M 4.68% 5
2019
Q1
$24.1M Buy
+255,295
New +$22.3M 2.99% 13
2016
Q4
Sell
-30,820
Closed -$3.22M 147
2016
Q3
$3.22M Buy
+30,820
New +$3.34M 0.26% 53

Other funds holding CELG

Gardner Lewis Asset Management's CELG Position: Q4 2019 in Review

Gardner Lewis Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 528,711 shares — an estimated $52.5M sold.

Gardner Lewis Asset Management first reported a position in CELG in Q3 2016 and held it in 4 quarters. The position peaked at $52.5M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gardner Lewis Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 528,711 Celgene Corp shares in Q4 2019, an estimated $52.5M.
  • Gardner Lewis Asset Management first reported a position in Celgene Corp in Q3 2016 and held it in 4 quarters.
  • Gardner Lewis Asset Management's Celgene Corp position peaked at $52.5M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.